Menu
welches kollagen für haut, kollagen was beachten, kollagen was hilft wirklich,

What is ELLANSÉ?

The dual-action dermal filler that delivers instant results with long lasting benefits.

hear from Dr Shang Li
Model is not an actual patient.

Ellansé is the only dermal filler to achieve instant volume and long-lasting results, using own-collagen stimulation; to deliver brighter skin with improved density, firmness and elasticity.

How ELLANSÉ is different

The science behind the stimulation

Combining smooth PCL microspheres with a CMC-based carrier gel, Ellansé gets to work immediately, filling the areas affected by volume loss. The microspheres then degrade over time - leaving behind collagen structures that steadily rebuild and reshape facial contours, to restore the youthful infrastructure of the skin. It has along-lasting effect, so reduces the need for top up treatments.
07
Model is not an actual patient.

The purpose of fillers

From the age of 25, the face loses around 1% of its volume per year. This is because the collagen in the skin breaks down, making the skin thinner and drier and causing wrinkles. Hence, the primary purpose of filler products is to compensate for these losses. But what are the choices?
08
Model is not an actual patient.

A fast and noticeable improvement in skin quality.

Hyaluronic acid-based products simply improve volume in the short-term. However, collagen biostimulating products not only deliver rapid results, but also improve the quality of the skin in the medium and long term, so their effect is sustained.
Sinclair Ellanse Shot 04 070
Model is not an actual patient.

Choice is the deciding factor

We can employ temporary products which remain in the skin for between 3-8 months; we can use collagens or hyaluronic acids (which are simply fillers - the injected volume is the only effective change); or we can apply durable products, which have lasting effect from 18 months to 2 years,* such as ELLANSÉ, a Polycaprolactone-based filler (with a secondary action that stimulates the natural production of collagen for more enduring results).
03
Model is not an actual patient.

Ideal for deep volumes and rejuvenation

Ellansé contains Polycaprolactone (PCL) microspheres – an effective and safe component to use over long periods, closing the gap between surgical and non-invasive treatments.
02
Model is not an actual patient.
Learn More

ELLANSÉ works deep under the skin

Before Treatment Mode Of Action Video

Before treatment

Depleted collagen, elastin and hyaluronic acid lead to lines, wrinkle sand volume loss.
Immediate Restoration Of Volume Ellanse Collagen

Immediate restoration of volume

ELLANSÉ contains smooth microspheres (tiny particles), evenly distributed in the carrier gel, which fill the areas of the skin affected by volume loss.
Stimulation Of Your Body Natural Collagen Production Ellanse

Stimulation of your body’s natural collagen production

Over the course of a few months, the presence of smooth microspheres boosts your body’s natural collagen production.
See real patient results

Mode of Action

ELLANSÉ works deep under the skin

ELLANSÉ works deep under the skin

ELLANSÉ contains smooth microspheres (tiny particles), evenly distributed in the carrier gel, which fills the areas of the skin affected by volume loss.

Instant results from the first session

An advantage of ELLANSÉ is that a single* session is enough to correct and rejuvenate (depending on the lack of tissue and ageing of the skin).

ELLANSÉ can be applied with an anesthetic cream or local anesthetic injection to ensure totally pain-free administration.

Continue the conversation
*Individual results may vary, multiple sessions may be required depending on the individual. Model is not an actual patient.
Model Image 20

How ELLANSÉ compares to other available treatments

Ellanse Radiesse Sculptra Table Comparison

Continue your Education

Model Image 16

View real patient results

The power is in the results, see them for yourself - here.
Model Image 25

Ready to talk to a physician?

Use our physician finders or speak to us about finding a ELLANSÉ physician near you.
Model Image 22

Learn more with our F&Q

Find answers to yours questions, if you still need more information contact us.
Find Your Clinic

INDICATION:

The EU approved intended use is: Ellansé (a Poly-ɛ-caprolactone-based dermal filler) is an injectable implant, indicated for subdermal implantation in the face for the lasting correction of wrinkles and facial aging signs or conditions.

INDICATION:

The EU approved intended use is: Ellansé (a Poly-ɛ-caprolactone-based dermal filler) is an injectable implant, indicated for subdermal implantation in the face for the lasting correction of wrinkles and facial aging signs or conditions.

Important Safety Considerations:

Like all procedures of this type there is a possibility of adverse events, although not everybody experiences them. These adverse events include but are not limited to infection, minimal acute inflammatory tissue reaction (redness, swelling, rash, oedema, erythema, lumps/nodules etc.), pain (which may be temporary or persistent in nature), transient haematoma or bruising.

Other potential adverse events include

- Injection related reactions, include itching, discoloration or tenderness may occur at the site of the injection. These usually resolve spontaneously within several days after the injection.

- As with any implant material possible adverse reactions that may occur include, but are not limited to the following: hypersensitivity, allergic reactions, inflammation, infection, fistula formation, haematoma, seroma, extrusion, induration formation, inadequate healing, skin discoloration, oedema, contusions/bruises, ecchymosis, inadequate or excessive augmentation, loss of correction, interference with local circulation if injected into a blood vessel resulting in vessel laceration, occlusion, embolism, infarction, and abscess at implant site which may result in induration and/or scar formation.

- Rare but serious adverse events associated with the intravascular injection of soft tissue fillers in the face have been reported and include temporary or permanent vision impairment, blindness, cerebral ischemia or cerebral hemorrhage, leading to stroke, skin necrosis, damage to underlying facial structures, nausea and vomiting, lack of ocular movement, significant skin changes, ptosis, exotropia and neurological complications.

- Adverse events, other than mentioned above, could occur as can be with any medical intervention.

All (potential) adverse side effects and incidents should be reported immediately to the Sinclair Corporate Safety Group: quality@sinclair.com

For a full list of contraindications, warnings, and precautions for this product please visit http://www.sinclairpharma.com/eifu/ for a copy of the Product Instructions for Use.